The Australian Financial Review takes a look at InteliCare’s initial public offering (IPO) and why it could be one of the only companies not pausing its run.

InteliCare is looking to raise $5.5 million through the issue of 27.5 million shares priced at 20¢ each, according to its prospectus lodged with ASIC.

View the prospectus (PDF)

Read the AFR’s full rundown on InteliCare’s IPO